Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
for Hematologic Malignancy
29 locations incl. Los Angeles
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Sex: All·Age: 1 - 21
Code: NCT05476770·Phase 1·Recruiting